Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage
Khakoo, S.I., Coles, C.J., Armstrong, J.S. and Barry, R.E. (1995) Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage. Journal of Clinical Gastroenterology, 20, (3), 244-247. (PMID:7797836).
Download
Full text not available from this repository.
Description/Abstract
3,4-Methylenedioxymetamphetamine ("ecstasy") has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.
| Item Type: | Article |
|---|---|
| ISSNs: | 0192-0790 (print) 1539-2031 (electronic) |
| Related URLs: | |
| Keywords: | 3,4-methylenedioxymetamphetamine, liver, fibrosis, drug reaction, toxicity |
| Subjects: | R Medicine > RC Internal medicine |
| Divisions: | Faculty of Medicine > Infection, Inflammation and Immunity |
| Item ID: | 337659 |
| Date Deposited: | 22 Jun 2012 13:11 |
| Last Modified: | 22 Jun 2012 13:11 |
| Contributors: | Khakoo, S.I. (Author) Coles, C.J. (Author) Armstrong, J.S. (Author) Barry, R.E. (Author) |
| Date: | April 1995 |
| Status: | Published |
| URI: | http://eprints.soton.ac.uk/id/eprint/337659 |
Actions (login required)
 |
View Item |
